A marketing agency that knows the content demand of MedTech, working at the pace of AI.
The website. The sales deck. Months of social. Email. The trade show wall. KOL decks, training materials, investor updates. Every channel wants its own version, at its own size, on its own schedule. Then the next product starts, and the first one still needs feeding.
Keeping up used to mean hiring a large team. It doesn't anymore.
Build a launch library that feeds every sales and marketing channel you have.










Language models. Image and motion generators. Voice. Research agents. We work with the modern AI stack every day — we know what each tool does well, where each one fails, and how to make them work together for MedTech content.
Each tool solves a specific problem. None of them ship on their own. Senior creative direction is what turns them into a launch library that clears review.
TYBR Health needed a full post-clearance content ecosystem for B3 Gel: brand, web, product story, MOA animation, sales materials, campaign creative, and the visual assets their team could keep using after launch. AI accelerated the volume; senior direction kept the work MedTech-accurate.
View TYBR work →
See how we leverage AI to build a scaled content program for your MedTech product.
No. Generated imagery is what you get from a prompt. What's on this page is what you get from a creative director briefing the tools, rejecting most of what comes back, and directing the next round. The difference isn't visible in the tool. It's visible in the work.
Photos are enough to start, which is the point of the example above. If you have CAD, better: it becomes the source of truth for geometry and we build from it. If you don't, or the device isn't in production yet, we can still get you to a full library. What you bring changes the route, not the destination.
AI doesn't know what your device does, and it will happily invent a port that doesn't exist. Every output is checked against the real product by a person before it leaves the studio, and anything that makes a technical or clinical claim goes through the same review any Vuelab asset does. Where accuracy matters most, mechanism of action and anatomy, we still build in 3D, because that's where control lives.
Alongside it. Mechanism of action, surgical procedure, and anything that has to be anatomically exact are still built in our 3D pipeline. What this method changes is everything around that: the renders, the environments, the social volume, the campaign creative, the hundred assets a launch needs beyond the hero film. The two share one visual language, so the library reads as one device.
You do, on the same terms as any Vuelab engagement, for every channel you sell in. We only work with tools that meet our data-handling standards, so your product, your unreleased work, and anything sensitive stay protected. [TODO(Tim): confirm this wording against the standard agreement.]
Days, not months, once the direction is set. The direction is where the time goes: understanding the device, its category, and what each channel needs from it. Skip that and you get volume without a point of view, which is what most AI content looks like.
Yes, always. You know what you're buying and what you're putting your name on. We've been upfront about this since we started using these tools, and we'd rather lose a project than blur it.
Usually as the production capacity they don't have. Your team knows the product and the market; we give them a library to work from and a partner who can produce at the volume a twelve-month sales cycle needs. If you don't have a team, that's a different conversation, and it's the next box down.